# ENDOCHAIN Implementation & Clinical Operations Manual

**Creator:** Ariel Viduya Manosca | **Author:** IAMVC holdings LLC

**Version:** 2.0  
**Date:** November 2025  
**Audience:** Clinical Implementers, IT Administrators, Healthcare Providers

---

## 1. Pre-Implementation Checklist

### 1.1 Institutional Requirements

- [ ] **IRB/Ethics Approval:** Obtain approval for clinical validation or patient assessment
- [ ] **HIPAA/PRIVACY COMPLIANCE:** Business Associate Agreements (BAAs) with ENDOCHAIN
- [ ] **CLIA CERTIFICATION:** Clinical laboratory standards if on-site analysis used
- [ ] **EHR INTEGRATION:** API credentials from hospital information system
- [ ] **NETWORK INFRASTRUCTURE:** Minimum 10 Mbps dedicated bandwidth; VPN access
- [ ] **STAFF TRAINING:** Identify 2–3 clinician champions; schedule 4-hour training
- [ ] **HARDWARE PROVISIONING:** 
  - [ ] Regenerative Spark Lattice (RSL) device + charging station
  - [ ] Ethernet connection or WiFi 6 for data transmission
  - [ ] DICOM PACS workstation integration (if imaging-based workflow)
- [ ] **BUDGET ALLOCATION:** Per-assessment licensing; platform integrations

---

## 2. Installation & System Setup

### 2.1 Cloud Deployment (AWS)

**Step 1: AWS Account Setup**
```bash
# Create IAM user with programmatic access
aws iam create-user --user-name endochain-deployer
aws iam attach-user-policy --user-name endochain-deployer \
  --policy-arn arn:aws:iam::aws:policy/PowerUserAccess

# Generate credentials
aws iam create-access-key --user-name endochain-deployer
# → Save AWS_ACCESS_KEY_ID and AWS_SECRET_ACCESS_KEY securely
```

**Step 2: Deploy Infrastructure via Terraform**
```bash
cd endochain-deployment/terraform

# Initialize Terraform
terraform init

# Review planned infrastructure
terraform plan -var="environment=production" \
               -var="region=us-east-1" \
               -out=tfplan

# Apply deployment
terraform apply tfplan

# Outputs: RDS endpoint, ECS cluster name, API Gateway URL
terraform output
```

**Step 3: Initialize Database**
```bash
# Connect to RDS
psql -h <RDS_ENDPOINT> -U postgres -c "CREATE DATABASE endochain_prod;"

# Run migrations
python3 endochain/migrate.py --env production
```

**Step 4: Deploy Containerized Services**
```bash
# Push Docker images to ECR
aws ecr get-login-password --region us-east-1 | \
  docker login --username AWS --password-stdin <ECR_REGISTRY>

docker build -t endochain/vlg-engine:2.0 ./vlg_engine
docker tag endochain/vlg-engine:2.0 <ECR_REGISTRY>/vlg-engine:2.0
docker push <ECR_REGISTRY>/vlg-engine:2.0

# Deploy via ECS
aws ecs update-service --cluster endochain-prod \
  --service vlg-engine \
  --force-new-deployment
```

### 2.2 On-Premise Deployment (Docker Compose)

**System Requirements:**
- **OS:** Ubuntu 22.04 LTS or RHEL 8.x
- **CPU:** 8-core minimum; 16-core recommended
- **RAM:** 32 GB minimum
- **Storage:** 500 GB SSD for data; 1 TB for long-term backups
- **Network:** 10 Mbps minimum uplink; firewall rule for port 443

**Installation Script:**
```bash
#!/bin/bash
set -e

# Install dependencies
sudo apt-get update && sudo apt-get install -y \
    docker.io \
    docker-compose \
    postgresql-client \
    curl

# Add user to docker group
sudo usermod -aG docker $USER

# Clone ENDOCHAIN repository
git clone https://github.com/iamvc/endochain.git
cd endochain

# Create environment file
cat > .env << EOF
ENVIRONMENT=production
DB_PASSWORD=$(openssl rand -base64 32)
JWT_SECRET=$(openssl rand -base64 32)
GOOGLE_API_KEY=<INSERT_KEY>
AZURE_API_KEY=<INSERT_KEY>
TLS_CERT_PATH=/etc/endochain/certs/server.crt
TLS_KEY_PATH=/etc/endochain/certs/server.key
EOF

# Generate self-signed TLS certificates (or use CA-signed)
mkdir -p /etc/endochain/certs
openssl req -x509 -newkey rsa:4096 -keyout /etc/endochain/certs/server.key \
  -out /etc/endochain/certs/server.crt -days 365 -nodes

# Launch services
docker-compose -f docker-compose.prod.yml up -d

# Health check
sleep 10
curl -k https://localhost/health
echo "✓ ENDOCHAIN services running"
```

---

## 3. Clinical Workflow Integration

### 3.1 Patient Enrollment & Data Collection

**Workflow Step 1: Patient Registration**

```
┌──────────────────────────────────────┐
│ 1. Patient Scheduling Appointment    │
├──────────────────────────────────────┤
│ • Enroll in ENDOCHAIN study/clinical │
│ • Confirm diagnostic visit (+/- imaging)
│ • Schedule 96-hour V-CAW window      │
└──────────────────────────────────────┘
              ↓
┌──────────────────────────────────────┐
│ 2. Pre-Assessment Questionnaire      │
├──────────────────────────────────────┤
│ • Via Azure Health Bot chatbot       │
│ • Symptom severity (visual analog)   │
│ • Menstrual history (LMP, cycle)     │
│ • Medical/surgical comorbidities     │
│ • Medications (esp. hormonal agents) │
│ • Estimated ovulation date           │
└──────────────────────────────────────┘
              ↓
┌──────────────────────────────────────┐
│ 3. Clinical Encounter                │
├──────────────────────────────────────┤
│ • Physical exam (abdominal, pelvic)  │
│ • Blood/saliva sampling (if consented)
│ • Imaging (transvaginal ultrasound)  │
│ • RSL device electrode placement     │
└──────────────────────────────────────┘
              ↓
┌──────────────────────────────────────┐
│ 4. V-CAW Data Collection (96 hours)  │
├──────────────────────────────────────┤
│ • RSL impedance sampling (hourly)    │
│ • Patient symptom logs (4 samples/day)
│ • Cycle day confirmation (LH strips) │
│ • Lab biomarkers (if available)      │
└──────────────────────────────────────┘
```

**Data Entry Form (FHIR-Compliant):**

```html
<form id="endochain-intake">
  <fieldset>
    <legend>ENDOCHAIN Patient Assessment (v2.0)</legend>
    
    <!-- Demographics -->
    <label>Patient ID: <input type="text" name="patient_id" readonly></label>
    <label>Date of Birth: <input type="date" name="dob" required></label>
    <label>Gender: 
      <select name="gender">
        <option value="female">Female</option>
        <option value="other">Other</option>
      </select>
    </label>
    
    <!-- Cycle Information -->
    <label>Last Menstrual Period (LMP):
      <input type="date" name="lmp" required>
    </label>
    <label>Cycle Length (days):
      <input type="number" name="cycle_length" min="21" max="35">
    </label>
    <label>Estimated Ovulation Date:
      <input type="date" name="estimated_ovulation" required>
    </label>
    
    <!-- Symptom Assessment (Visual Analog Scale) -->
    <label>Pelvic Pain Severity (0–10):
      <input type="range" name="pain_severity" min="0" max="10">
      <span id="pain-value">0</span>/10
    </label>
    
    <label>Dysmenorrhea Severity (0–10):
      <input type="range" name="dysmenorrhea" min="0" max="10">
    </label>
    
    <label>Dyspareunia (Pain During Intercourse):
      <input type="checkbox" name="dyspareunia"> Yes
    </label>
    
    <!-- Imaging & Lab Data -->
    <label>Imaging Type:
      <select name="imaging_type">
        <option>None</option>
        <option>Transvaginal Ultrasound (DICOM)</option>
        <option>MRI Pelvis (DICOM)</option>
        <option>Other</option>
      </select>
    </label>
    
    <label>Upload DICOM File:
      <input type="file" name="dicom_file" accept=".dcm">
    </label>
    
    <!-- RSL Device Data -->
    <label>RSL Device Serial Number:
      <input type="text" name="rsl_device_id" required>
    </label>
    
    <button type="submit">Submit Assessment</button>
  </fieldset>
</form>
```

### 3.2 Real-Time Assessment Workflow

**Clinician Dashboard (Real-time):**

```
╔════════════════════════════════════════════════════════╗
║         ENDOCHAIN Clinical Dashboard v2.0             ║
║════════════════════════════════════════════════════════║
║                                                        ║
║ Patient: ENDO-2025-001234 | Age: 34 | Cycle: Day 12  ║
║ Status: 🟢 Assessment In Progress (67% complete)     ║
║                                                        ║
║ ┌────────────────────────────────────────────────┐   ║
║ │ PLATFORM STATUS MONITOR                        │   ║
║ ├────────────────────────────────────────────────┤   ║
║ │ ✓ Med-Gemini (Complete)        Confidence: 89% │   ║
║ │ ✓ Azure Health Bot (Complete)  Triage: Level 3 │   ║
║ │ ✓ Aidoc Radiology (Complete)   Flag: Normal    │   ║
║ │ ⏳ Viz.ai Vascular (80% done)    ETA: 12 sec    │   ║
║ │ ⏳ Tempus Genomic (60% done)     ETA: 28 sec    │   ║
║ │ ⏳ OpenEvidence (Pending)        Queue: 2 ahead │   ║
║ │ ⏳ VLG Inference (Queued)        Dependencies:3 │   ║
║ └────────────────────────────────────────────────┘   ║
║                                                        ║
║ ┌────────────────────────────────────────────────┐   ║
║ │ PRELIMINARY FINDINGS                           │   ║
║ ├────────────────────────────────────────────────┤   ║
║ │ Med-Gemini Symptoms:                           │   ║
║ │   • Chronic dysmenorrhea (HIGH confidence)     │   ║
║ │   • Dyspareunia (MODERATE confidence)          │   ║
║ │   • Dyschezia (LOW confidence)                 │   ║
║ │                                                 │   ║
║ │ Aidoc Imaging:                                 │   ║
║ │   • Uterine echotexture: Heterogeneous        │   ║
║ │   • Adenomyosis probability: 73%              │   ║
║ │   • Confidence: 81%                            │   ║
║ └────────────────────────────────────────────────┘   ║
║                                                        ║
║ [← Back]  [Pause]  [Force Complete]  [Cancel]        ║
╚════════════════════════════════════════════════════════╝
```

### 3.3 Final Assessment & Clinician Review

**ENDOCHAIN Report Template:**

```
═══════════════════════════════════════════════════════
    ENDOCHAIN DIAGNOSTIC ASSESSMENT REPORT v2.0
═══════════════════════════════════════════════════════

PATIENT INFORMATION
─────────────────────────────────────────────────────
Patient ID:              ENDO-2025-001234
Name:                    [De-identified]
Date of Birth:           [Shifted for privacy]
Age:                     34 years
Assessment Date:         2025-11-26 07:30 UTC
Menstrual Cycle Day:     12 (within V-CAW window)

═══════════════════════════════════════════════════════

PRIMARY DIAGNOSIS: Stage-0 Endometriosis (Early-Stage)
Confidence Level:  91.4% (Strong Evidence)

═══════════════════════════════════════════════════════

ENDOCHAIN CORE FINDINGS
─────────────────────────────────────────────────────

1. LEGENDRE ENDOMETRIAL INDEX–VIDUYA (LEI-V)
   ┌─────────────────────────────────────┐
   │ LEI-V Score:        0.02741         │
   │ Confidence:         94.7%           │
   │ Clinical Stage:     0 (Early)       │
   │ Viduya Legacy Glyph: Intersection   │
   │   Point Φ₅.₃₇ (Homology H₁)        │
   └─────────────────────────────────────┘

2. ENSEMBLE CONSENSUS (7 Platforms)
   ┌─────────────────────────────────────┐
   │ Med-Gemini:        Stage 0 (89%)    │
   │ Azure Health Bot:  Triage 3 (87%)   │
   │ Aidoc:             Normal/Mild (79%)│
   │ Viz.ai:            Risk 0.034 (86%) │
   │ OpenEvidence:      Strong Ev. (88%) │
   │ Tempus Genomic:    62 Percentile(72%)
   │ VLG Core:          Stage 0 (95%)    │
   │ ─────────────────────────────────   │
   │ CONSENSUS:         Stage 0 (91%)    │
   └─────────────────────────────────────┘

3. REGENERATIVE SPARK LATTICE (RSL) DATA
   ┌─────────────────────────────────────┐
   │ Measurement Window:  96 hours       │
   │ Z₅₀ₖHz:            4200 Ω (normal) │
   │ Z₁₀₀ₖHz:           3850 Ω (↓)      │
   │ Z₁ₘHz:             2100 Ω (↓)      │
   │ Impedance Trend:    Decreasing      │
   │ Interpretation:    Early inflammation
   │                    (consistent with │
   │                     Stage-0 endo)   │
   └─────────────────────────────────────┘

4. PLATFORM-SPECIFIC DETAILS

   A) MEDICAL SYMPTOM ANALYSIS (Med-Gemini)
   ─────────────────────────────────────
   • Dysmenorrhea onset: 24 months ago
   • Dyspareunia pattern: Deep, intermittent
   • Neuropathic phenotype: Possible (TNF-α elevation)
   • Symptom encoding: [0.87, 0.92, 0.34, 0.71, ...]
   • Confidence: 89.5%

   B) RADIOLOGY INTERPRETATION (Aidoc)
   ─────────────────────────────────────
   • Imaging type: Transvaginal ultrasound
   • Uterine size/shape: Normal
   • Uterine echotexture: Heterogeneous (mild)
   • Adenomyosis scoring: 73% probability
   • Adenomyotic cysts: 0
   • Endometrial thickness: 11 mm (normal)
   • Adnexal lesions: None
   • Confidence: 79.3%

   C) VASCULAR ANALYSIS (Viz.ai)
   ─────────────────────────────────────
   • Perfusion asymmetry index: 1.43
   • Right adnexal hypoperfusion: 8.2 cc
   • Neovascularization pattern: Yes (subtle)
   • Vascular risk score: 0.034
   • Recommendation: Monitor; consider repeat
     imaging in 3 months
   • Confidence: 85.6%

   D) GENOMIC RISK (Tempus AI)
   ─────────────────────────────────────
   • Endometriosis genetic risk: 62nd percentile
   • Key variants detected:
     - KRAS p.G12D (pathogenic)
     - CDKN2A loss (frameshift)
   • Pathway enrichment:
     - MAPK signaling (high enrichment)
     - Cell cycle regulation (moderate)
   • Clinical implication: Moderate genetic
     predisposition to endometriosis
   • Confidence: 72.1%

   E) EVIDENCE SYNTHESIS (OpenEvidence)
   ─────────────────────────────────────
   • Literature citations synthesized: 47
   • Citation strength score: 0.88
   • Key supporting studies:
     - Journal of Minimally Invasive Gynecology
       (2023): AI diagnostic accuracy >90%
     - Human Reproduction (2024): Early
       intervention improves QoL
   • Evidence quality: Moderate to Strong

═══════════════════════════════════════════════════════

CLINICAL RECOMMENDATIONS
─────────────────────────────────────────────────────

PRIMARY MANAGEMENT
──────────────────
1. MEDICAL THERAPY (First-Line)
   • GnRH agonist (leuprolide acetate)
     - Dose: 3.75 mg IM monthly × 3 months
     - Add-back: Norethindrone 5 mg daily
   OR
   • Progestin-only therapy
     - Oral: Dienogest 2 mg BID × 3 months
     - Injectable: Medroxyprogesterone 150 mg IM Q12W

2. SYMPTOM MANAGEMENT
   • NSAIDs (ibuprofen 600 mg TID) as needed
   • Heat therapy for dysmenorrhea
   • Pelvic floor physical therapy (referral)

FOLLOW-UP SCHEDULE
──────────────────
• 4 weeks: Clinical reassessment (pain scores)
• 12 weeks: Repeat ENDOCHAIN assessment
  - Compare LEI-V score (expect decline with Rx)
  - Evaluate therapy response
• 6 months: Consider imaging confirmation (if desired)

SPECIALIST REFERRAL
───────────────────
✓ RECOMMENDED: Reproductive Endocrinology &
  Infertility (REI) specialist

Rationale: Stage-0 confirmation + optimized medical
management; fertility planning given age (34).

PATIENT COUNSELING POINTS
─────────────────────────
• Endometriosis is chronic but manageable
• Early medical intervention improves prognosis
• Symptom tracking important; use patient portal
• Support groups available (RESOLVE.org)
• Genetics non-deterministic; management personalized

═══════════════════════════════════════════════════════

AUDIT TRAIL & COMPLIANCE
─────────────────────────────────────────────────────

Assessment ID:          ENDO-2025-001234-A1
SHA-256 Hash:           a3f7b8c9d2e1f0a8b7c6d5e4f3a2b1c0
                        d9e8f7a6b5c4d3e2f1a0b9c8d7e6f5
Timestamp (UTC):        2025-11-26T07:30:00Z
System Version:         ENDOCHAIN-VIDUYA-2025 (v2.0)
Creator Institution:    IAMVC holdings LLC
HIPAA Compliant:        ✓ Yes
FHIR Validated:         ✓ Yes (R4)
Clinician Reviewer:     [Signature: Dr. Smith]
Review Timestamp:       2025-11-26T07:45:00Z

═══════════════════════════════════════════════════════

NEXT STEPS FOR CLINICIAN
─────────────────────────────────────────────────────
□ Review assessment report with patient
□ Prescribe recommended therapy
□ Schedule 4-week follow-up
□ Document in EHR (FHIR export attached)
□ Consider referral to REI specialist
□ Provide patient education materials
□ Enable patient portal for symptom tracking

═══════════════════════════════════════════════════════

Report Generated By: ENDOCHAIN v2.0
For Questions: support@iamvc.org | 1-800-ENDOCHAIN
```

---

## 4. Staff Training & Competency

### 4.1 Clinician Training Module (4 hours)

**Session 1: ENDOCHAIN Science & Philosophy (1 hour)**
- Overview of Viduya Legacy Glyph methodology
- LEI-V score interpretation
- Stage assignment logic
- Evidence base & clinical validation data

**Session 2: Platform Integrations & Interpretation (1 hour)**
- Each platform's role (Med-Gemini, Aidoc, etc.)
- Confidence scoring & discordance handling
- Reading & interpreting platform outputs
- Troubleshooting common issues

**Session 3: Clinical Workflow & Hands-On Demo (1.5 hours)**
- Live patient enrollment walkthrough
- Data entry best practices
- Regenerative Spark Lattice device operation
- Dashboard navigation; report generation

**Session 4: Case Studies & Quality Assurance (0.5 hours)**
- Review 5 real case scenarios
- Diagnostic accuracy patterns
- When to escalate or defer judgment
- Competency assessment quiz (80% pass threshold)

### 4.2 IT Administrator Training (2 hours)

- HIPAA security & access controls
- Database backups & disaster recovery
- Monitoring dashboard & alerting
- Troubleshooting API connectivity
- Maintenance scheduling & patches

---

## 5. Quality Assurance & Validation

### 5.1 Monthly QA Audits

**Audit Checklist:**
- [ ] System uptime log (target: 99.95%)
- [ ] API latency metrics (p95 <3 sec)
- [ ] Platform consensus agreement rate (target: >96%)
- [ ] FHIR validation failure rate (target: <0.1%)
- [ ] HIPAA audit log review (no unauthorized access)
- [ ] Backup & restore test (successful completion)
- [ ] Clinician satisfaction survey (10+ responses)
- [ ] Patient safety incident review (zero harm events)

### 5.2 Continuous Monitoring

**Alert Thresholds:**

| Metric | Warning | Critical | Action |
|--------|---------|----------|--------|
| API Latency (p95) | >2.5 sec | >5 sec | Page on-call; scale |
| Platform Success Rate | <99% | <97% | Investigate; notify vendor |
| Database Connection Pool | >85% | >95% | Tune queries; add replicas |
| HIPAA Audit Events (anomalies) | >10/day | >50/day | Escalate to compliance |

---

## 6. Patient Portal & Engagement

### 6.1 Patient-Facing Features

**ENDOCHAIN Patient Portal:**

```
╔═══════════════════════════════════════════════════╗
║      ENDOCHAIN Patient Portal (My Assessment)    ║
╠═══════════════════════════════════════════════════╣
║                                                   ║
║ Welcome, [Patient Name]                          ║
║ ───────────────────────────────────────          ║
║                                                   ║
║ 📋 MY LATEST ASSESSMENT                         ║
║ ┌──────────────────────────────────────────────┐║
║ │ Date: Nov 26, 2025                           ││
║ │ Diagnosis: Stage-0 Endometriosis             ││
║ │ Confidence: 91.4%                            ││
║ │ Status: Reviewed by Dr. Smith ✓              ││
║ │                                               ││
║ │ [View Full Report] [Download PDF]            ││
║ └──────────────────────────────────────────────┘║
║                                                   ║
║ 📊 SYMPTOM TRACKER                              ║
║ ┌──────────────────────────────────────────────┐║
║ │ Track daily: Pain, mood, activity level      ││
║ │ [Log Today's Symptoms]                       ││
║ │                                               ││
║ │ Past 30 Days: Chart trends                   ││
║ │ [View Graph]                                 ││
║ └──────────────────────────────────────────────┘║
║                                                   ║
║ 💊 MY TREATMENT PLAN                            ║
║ ┌──────────────────────────────────────────────┐║
║ │ GnRH Agonist (Leuprolide 3.75 mg IM)         ││
║ │ Prescribed: Nov 26 | Started: Nov 28        ││
║ │ Refills: 2 remaining                         ││
║ │                                               ││
║ │ [View Medication Details]                    ││
║ │ [Set Injection Reminders]                    ││
║ └──────────────────────────────────────────────┘║
║                                                   ║
║ 📞 NEXT APPOINTMENT                             ║
║ ┌──────────────────────────────────────────────┐║
║ │ Date: December 26, 2025 @ 2:00 PM            ││
║ │ Location: OB/GYN Clinic, Room 304            ││
║ │ Provider: Dr. Sarah Smith, MD                ││
║ │                                               ││
║ │ [Reschedule] [Cancel] [Add to Calendar]      ││
║ └──────────────────────────────────────────────┘║
║                                                   ║
║ 📚 EDUCATION & RESOURCES                        ║
║ ├──────────────────────────────────────────────┤║
║ │ • What is Stage-0 Endometriosis?             ║
║ │ • GnRH Agonist: How It Works                 ║
║ │ • Pelvic Floor Therapy Near You              ║
║ │ • Support Community (RESOLVE)                ║
║ │ • FAQ: Endometriosis & Fertility             ║
║ └──────────────────────────────────────────────┘║
║                                                   ║
║ [Settings] [Contact Support] [Logout]          ║
╚═══════════════════════════════════════════════════╝
```

### 6.2 Patient Educational Materials

**ENDOCHAIN Patient Guide (Excerpt):**

```
UNDERSTANDING YOUR ENDOMETRIOSIS DIAGNOSIS
═════════════════════════════════════════════

Q: What does "Stage-0 Endometriosis" mean?
A: Your endometrium (uterine lining) shows early 
   signs of abnormal tissue growth. This is the 
   EARLIEST stage before significant symptoms develop. 
   Catching it now means better outcomes!

Q: How confident is this diagnosis?
A: ENDOCHAIN combined analysis from 7 AI platforms
   plus proprietary geometric analysis (Viduya Legacy
   Glyph). Confidence: 91.4% — very high!

Q: Will I need surgery?
A: Not necessarily! Early-stage disease usually 
   responds well to medical therapy (hormones). 
   Your doctor will discuss this with you.

Q: What happens next?
A1. Start prescribed medication (GnRH agonist)
A2. Track symptoms daily using the patient portal
A3. Follow-up visit in 4 weeks
A4. Repeat assessment in 12 weeks (track progress)

Q: Can I still get pregnant?
A: Yes! Endometriosis doesn't prevent pregnancy, but
   it can make conceiving harder. We'll discuss family
   planning with you and a fertility specialist.
```

---

## 7. Troubleshooting & Support

### 7.1 Common Issues & Resolution

| Issue | Root Cause | Solution |
|-------|-----------|----------|
| "Platform timeout" error | Platform API down | Check vendor status page; queue retry |
| RSL device won't connect | Bluetooth/USB issue | Restart device; check cable; reinstall drivers |
| LEI-V score unusually high | Data entry error | Validate patient biomarkers; resubmit |
| FHIR export fails | Schema mismatch | Verify FHIR validator; contact support |
| Patient can't access portal | SSO misconfiguration | Reset OAuth token; clear browser cache |

### 7.2 Escalation Path

```
LEVEL 1: Self-Service
└─→ Check FAQ, knowledge base, tutorials
└─→ Restart service/device

LEVEL 2: Helpdesk (support@iamvc.org)
└─→ Response time: <2 hours
└─→ Handles: Password resets, basic troubleshooting

LEVEL 3: Technical Support (engineering team)
└─→ Response time: <4 hours
└─→ Handles: API errors, database issues

LEVEL 4: Escalation (C-level review)
└─→ Response time: <24 hours
└─→ Handles: Critical incidents, privacy breaches
```

---

## 8. Regulatory Audits & Compliance Proof

### 8.1 HIPAA Audit Preparation

**Documentation Checklist:**
- [ ] Business Associate Agreement (BAA) on file
- [ ] HIPAA Security Risk Assessment (annual)
- [ ] Encryption audit (AES-256 at-rest)
- [ ] Access control logs (MFA enabled, RBAC enforced)
- [ ] Data breach response plan (tested quarterly)
- [ ] Staff training records (annual certification)
- [ ] Audit log review (no unauthorized access)
- [ ] Backup & recovery testing (quarterly)

### 8.2 CLIA Compliance (if applicable)

- Laboratory director certification
- High-complexity testing waiver (AI algorithms)
- Quality control logs
- Proficiency testing results
- Corrective action documentation

---

## 9. Maintenance & Updates

### 9.1 Scheduled Maintenance Windows

**Monthly (Sunday 2:00–3:00 AM EST):**
- Database optimization & index rebuild
- Security patches
- Backup verification

**Quarterly:**
- Full system upgrade
- Deep learning model retraining
- Penetration testing

**Annually:**
- Complete disaster recovery drill
- HIPAA security assessment
- Compliance audit

### 9.2 Update Procedure

```bash
# Backup current system
docker-compose exec db pg_dump endochain_prod > backup_$(date +%Y%m%d).sql

# Pull latest version
git pull origin main
docker-compose pull

# Perform migration (if schema changes)
python3 endochain/migrate.py --env production

# Restart services
docker-compose -f docker-compose.prod.yml restart

# Health check
curl https://localhost/health && echo "✓ Upgrade successful"
```

---

## 10. Contact & Support

**ENDOCHAIN Support Team**
- **Email:** support@iamvc.org
- **Phone:** 1-800-ENDOCHAIN (1-800-336-3624)
- **Hours:** Mon–Fri, 8 AM–6 PM PST
- **Emergency (24/7):** oncall@iamvc.org

**IAMVC Holdings LLC**
- **Address:** Las Vegas, NV
- **Web:** www.iamvc.org
- **Documentation:** docs.endochain.iamvc.org

---

**End of Implementation Manual**

*Version 2.0 | Last Updated: November 2025 | Next Review: May 2026*